On February 21, 2024, Adverum Biotechnologies, Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.62 USD | -5.81% | +3.67% | +1.22% |
Jun. 11 | Adverum Biotechnologies, Inc. Announces Executive Changes | CI |
May. 16 | Transcript : Adverum Biotechnologies, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 03:40 PM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.22% | 158M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- ADVM Stock
- News Adverum Biotechnologies, Inc.
- Adverum Biotechnologies, Inc. announced that it has received $127.5 million in funding from a group of investors